scPharmaceuticals Inc. Logo

scPharmaceuticals Inc.

Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.

SCPH | US

Overview

Corporate Details

ISIN(s):
US8106481059
LEI:
Country:
United States of America
Address:
25 BURLINGTON MALL ROAD, SUITE 203, 1803 BURLINGTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

scPharmaceuticals Inc. is a commercial-stage pharmaceutical company, operating as a subsidiary of MannKind Corporation, focused on developing and commercializing patient-centric treatments for cardiorenal diseases. The company specializes in drug-device combinations that facilitate subcutaneous drug delivery, aiming to improve patient outcomes and shift care from clinical settings to the home. Its flagship product, FUROSCIX®, is a proprietary formulation of furosemide delivered via an auto-injector for treating congestion in patients with heart failure and, as of 2025, chronic kidney disease. The company's strategy centers on creating value-based solutions that reduce the burden of care and enhance quality of life for patients with cardiovascular and renal conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all scPharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for scPharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for scPharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mineralys Therapeutics, Inc. Logo
Developing targeted treatments for hypertension & CKD driven by elevated aldosterone.
United States of America
MLYS
MiNK Therapeutics, Inc. Logo
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
MIRA PHARMACEUTICALS, INC. Logo
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America
MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America
MIRM
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium
MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan
4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea
142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden
MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan
4534
Moderna, Inc. Logo
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America
MRNA

Talk to a Data Expert

Have a question? We'll get back to you promptly.